Antibacterial activity of rifamycins for M. smegmatis with comparison of oxidation and binding to tear lipocalin.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2014-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbapap.2014.02.001PMID 24530503PMCID PMC3992280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel fluorescent lipid probe for dry eye: retrieval by tear lipocalin in humans.

  2013cited by this paper
• First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients with Advanced Solid Tumors

  2013cited by this paper
• Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles

  2012cited by this paper
• Genetic variants in antioxidant pathway: risk factors for hepatotoxicity in tuberculosis patients.

  2012cited by this paper
• The conserved disulfide bond of human tear lipocalin modulates conformation and lipid binding in a ligand selective manner.

  2011cited by this paper
• Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.

  2011cited by this paper
• Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes

  2011cited by this paper
• Synthesis and structure-activity relationships of novel substituted 8-amino, 8-thio, and 1,8-pyrazole congeners of antitubercular rifamycin S and rifampin.

  2011cited by this paper
• Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis

  2011cited by this paper
• Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine.

  2011cited by this paper
• WHO global tuberculosis control report 2010. Summary.

  2010cited by this paper
• What is solvatochromism?

  2010cited by this paper
• Re: Review article titled, "Rifamycins - Obstacles and opportunities" by Paul A. Aristoff, George A. Garcia, Paul D. Kirchhoff, H.D. Hollis Showalter. Tuberculosis 2010; 90(2):94-118.

  2010cited by this paper
• Gelatin nanocarriers as potential vectors for effective management of tuberculosis.

  2010cited by this paper
• Intracellular Mycobacterium avium intersect transferrin in the Rab11(+) recycling endocytic pathway and avoid lipocalin 2 trafficking to the lysosomal pathway.

  2010cited by this paper
• Rifamycins--obstacles and opportunities.

  2010cited by this paper
• DNA Cloning

  2009cited by this paper
• Intracavitary ligand distribution in tear lipocalin by site-directed tryptophan fluorescence.

  2009cited by this paper
• A new crystal form of human tear lipocalin reveals high flexibility in the loop region and induced fit in the ligand cavity.

  2009cited by this paper
• Lipid microsphere formulation containing rifampicin targets alveolar macrophages.

  2008cited by this paper
• Rifampin Resistance, Beijing-W Clade-Single Nucleotide Polymorphism Cluster Group 2 Phylogeny, and the Rv2629 191-C Allele in Mycobacterium tuberculosis Strains

  2008cited by this paper
• Role of Porins for Uptake of Antibiotics by Mycobacterium smegmatis

  2008cited by this paper
• Ligand binding site of tear lipocalin: contribution of a trigonal cluster of charged residues probed by 8-anilino-1-naphthalenesulfonic acid.

  2008cited by this paper
• Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra.

  2007cited by this paper
• Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis.

  2007cited by this paper
• Evidence for internal and external binding sites on human tear lipocalin.

  2007cited by this paper
• AsnB Is Involved in Natural Resistance of Mycobacterium smegmatis to Multiple Drugs

  2006cited by this paper
• A role for dendritic cells in the dissemination of mycobacterial infection.

  2006influential reference
• The Merck Index: an Encyclopedia of Chemicals, Drugs, and Biologicals. 14th Edition. Merck Inc., Whitehouse Station/Rahway, New Jersey, October 2006. Cloth 0-911910-00X. $125. pp. 2564.

  2006cited by this paper
• Oral Therapy Using Nanoparticle-Encapsulated Antituberculosis Drugs in Guinea Pigs Infected with Mycobacterium tuberculosis

  2005cited by this paper
• Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution?

  2005cited by this paper
• Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis.

  2005cited by this paper
• The 1.8-Å Crystal Structure of Human Tear Lipocalin Reveals an Extended Branched Cavity with Capacity for Multiple Ligands*

  2005cited by this paper
• Rifampicin Inhibits α-Synuclein Fibrillation and Disaggregates Fibrils

  2004cited by this paper
• Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.

  2004cited by this paper
• Tear lipocalin: potential for selective delivery of rifampin.

  2004influential reference
• Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils.

  2004cited by this paper
• A Rifampin-Hypersensitive Mutant Reveals Differences between Strains of Mycobacterium smegmatis and Presence of a Novel Transposon, IS1623

  2003influential reference
• Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects.

  2003cited by this paper
• Characterization of Mycobacterium tuberculosis mycothiol S-conjugate amidase.

  2003cited by this paper
• Safety and Bactericidal Activity of Rifalazil in Patients with Pulmonary Tuberculosis

  2001cited by this paper
• Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials

  2001cited by this paper
• Site-directed tryptophan fluorescence reveals the solution structure of tear lipocalin: evidence for features that confer promiscuity in ligand binding.

  2001cited by this paper
• The Merck index : an encyclopedia of chemicals, drugs, and biologicals

  2001cited by this paper
• Functional cavity dimensions of tear lipocalin

  2000cited by this paper
• Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.

  2000cited by this paper
• Susceptibility testing for mycobacteria.

  2000cited by this paper
• Binding studies of tear lipocalin: the role of the conserved tryptophan in maintaining structure, stability and ligand affinity.

  1999cited by this paper
• Side chain mobility and ligand interactions of the G strand of tear lipocalins by site-directed spin labeling.

  1999cited by this paper
• A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates.

  1999cited by this paper
• Effect of a new rifamycin derivative, rifalazil, on liver microsomal enzyme induction in rat and dog.

  1998cited by this paper
• Pharmacokinetics of KRM-1648, a new benzoxazinorifamycin, in rats and dogs

  1996cited by this paper
• In vitro protein binding characteristics of isoniazid, rifampicin, and pyrazinamide to whole plasma, albumin, and alpha-1-acid glycoprotein.

  1996cited by this paper
• In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis

  1996cited by this paper
• In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis

  1995cited by this paper
• Tear lipocalins bind a broad array of lipid ligands.

  1995cited by this paper
• Tissue expression of lipocalins in human lacrimal and von Ebner's glands: colocalization with lysozyme

  1995cited by this paper
• Assignment of tear lipocalin gene to human chromosome 9q34-9qter.

  1993influential reference
• cDNA cloning and sequencing reveals human tear prealbumin to be a member of the lipophilic-ligand carrier protein superfamily.

  1992cited by this paper
• Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis

  1990cited by this paper
• Thermally adaptive changes of mycolic acids in Mycobacterium smegmatis.

  1989cited by this paper
• Determination of rifampicin and its main metabolites in human plasma by high-performance liquid chromatography.

  1988cited by this paper
• Intraphagocytic penetration of antibiotics.

  1988cited by this paper
• Determination of molecular species composition of C80 or longer-chain alpha-mycolic acids in Mycobacterium spp. by gas chromatography-mass spectrometry and mass chromatography

  1986cited by this paper
• The Variable Reagent Blank: Protein Determination as a Model

  1985cited by this paper
• Rifampicin as a spectroscopic probe of the mechanism of RNA polymerase from E. coli

  1982cited by this paper
• Metal ion catalyzed oxidation of the antibiotic rifampicin.

  1977cited by this paper
• Implication of rifampicin-quinone in the irreversible binding of rifampicin to macromolecules.

  1976cited by this paper
• Chemical modifications and biological properties of rifamycins.

  1966cited by this paper
• Rifamycins. XLI. A new class of active semisynthetic rifamycins. N-substituted aminomethyl derivatives of rifamycin SV 2.

  1965cited by this paper
• New derivatives of rifamycin SV.

  1965cited by this paper
• Mechanisms of Oxidation with Oxygen

  1965cited by this paper

• Verapamil Suppresses the Development of Resistance Against Anti-Tuberculosis Drugs in Mycobacteria

  2025influential citation
• Adaptive Resistance Mutations at Suprainhibitory Concentrations Independent of SOS Mutagenesis

  2021cites this paper
• EFFECT OF VIRGIN COCONUT OIL ON MYCOBACTERIUM SMEGMATIS AND STAPHYLOCOCCUS AUREUS TREATED WITH EXTRACTS OF ZANTHOXYLUM ACANTHOPODIUM FRUIT

  2021cites this paper
• Tear Lipocalin and Lipocalin-Interacting Membrane Receptor

  2021cites this paper
• Repositioning rifamycins for Mycobacterium abscessus lung disease

  2019influential citation
• Phagomimetic action of antibiotics: Revisited. How do antibiotics know where to go?

  2019cites this paper
• Ligand binding studies by high speed centrifugal precipitation and linear spectral summation using ultraviolet–visible absorption spectroscopy

  2018cites this paper
• Interaction of ceramides and tear lipocalin.

  2018cites this paper
• Antimycobacterial activity of fruit of Zanthoxylum acanthopodium DC against Mycobacterium smegmatis

  2018cites this paper
• Formation, characterization and pH dependence of rifampicin: heptakis(2,6-di-O-methyl)-β-cyclodextrin complexes.

  2017cites this paper
• Mechanism of Rifampicin Inactivation in Nocardia farcinica

  2016cites this paper
• Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China

  2015cites this paper
• Restoration of structural stability and ligand binding after removal of the conserved disulfide bond in tear lipocalin.

  2014cites this paper